GP2 is a product and a source of collaboration. The individuals and groups that contribute to GP2 drive its strategy, its operations, and ultimately its impact. Read more.
At GP2, we are committed to creating a global research community with the tools and infrastructure to address emerging research needs and questions. Read more.
GP2 develops and maintains tools that assemble clinical and genetic data to help accelerate research across the Parkinson’s Disease Research community. Read more.
Online repository for "Multi-ancestry genome-wide meta-analysis in Parkinson’s disease" study with data from 49,049 PD cases, 18,785 proxy cases, and 2,458,063 controls of various ancestries.
PD African and African admixed Meta-analysis
Online repository for study on Parkinson's disease in African populations. Largest genome-wide assessment providing new insights into the disease's etiology.
Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
A multi-ancestry meta-analysis of Parkinson’s disease identified 78 significant genetic loci, including 12 new ones. The study involved over 49,000 cases and 2 million controls from diverse ancestries.
